{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:30:46Z","timestamp":1792089046964,"version":"4.4.0"},"reference-count":157,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.sxmr.2015.12.005","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T10:38:35Z","timestamp":1458383915000},"page":"270-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Useful Implications of Low-dose Long-term Use of PDE-5 Inhibitors"],"prefix":"10.1093","volume":"4","author":[{"given":"Taymour","family":"Mostafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2015.12.005_bib1","first-page":"2381","article-title":"Couple satisfaction to different therapeutic modalities for organic erectile dysfunction","volume":"5","author":"Hassan","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1185\/03007995.2013.791263","article-title":"A\u00a06-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction","volume":"29","author":"El-Meliegy","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.sxmr.2015.12.005_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5152\/tud.2015.46354","article-title":"Current use of phosphodiesterase inhibitors in urology","volume":"41","author":"Hakky","year":"2015","journal-title":"Turk J Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib4","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1345\/aph.1E487","article-title":"Phosphodiesterase 5 inhibitors for erectile dysfunction","volume":"39","author":"Setter","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sxmr.2015.12.005_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling","volume":"76","author":"Conti","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.sxmr.2015.12.005_bib6","first-page":"1098","article-title":"Heme oxygenase vs nitric oxide synthase in signalling mediating sildenafil citrate action","volume":"4","author":"Abdel Aziz","year":"2007","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib7","first-page":"1636","article-title":"The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues","volume":"5","author":"Aziz","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib8","first-page":"703","article-title":"Oral therapy for erectile dysfunction","volume":"63","author":"Eardley","year":"2010","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib9","series-title":"Viagra [package insert]","year":"2010"},{"key":"10.1016\/j.sxmr.2015.12.005_bib10","series-title":"Levitra [package insert]","year":"2011"},{"key":"10.1016\/j.sxmr.2015.12.005_bib11","series-title":"Cialis [package insert]","year":"2011"},{"key":"10.1016\/j.sxmr.2015.12.005_bib12","first-page":"102","article-title":"Modernity in the treatment of erectile dysfunction: Levitra (vardenafil) in the form of oral dispersible tablet","volume":"3","author":"Gamidov","year":"2013","journal-title":"Urologiia"},{"key":"10.1016\/j.sxmr.2015.12.005_bib13","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.2147\/DDDT.S94615","article-title":"Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in\u00a0vivo evaluation","volume":"9","author":"Fahmy","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.sxmr.2015.12.005_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2005.02553.x","article-title":"Tadalafil pharmacokinetics in healthy subjects","volume":"61","author":"Forgue","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1208\/s12249-014-0199-3","article-title":"Development and evaluation of Avanafil self-nanoemulsifying drug delivery system with rapid onset of action and enhanced bioavailability","volume":"16","author":"Fahmy","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.sxmr.2015.12.005_bib16","first-page":"701","article-title":"Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility","volume":"10","author":"Katz","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.sxmr.2015.12.005_bib17","first-page":"485","article-title":"Efficacy of avanafil 15 minutes after dosing in men with erectile dysfunction: A randomized, double-blind, placebo controlled study","volume":"194","author":"Hellstrom","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib18","first-page":"2502","article-title":"Oral phosphodiesterase type 5 inhibitors: Nonerectogenic beneficial uses","volume":"5","author":"Mostafa","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2013.07.004","article-title":"Repeated and chronic administration of Vardenafil or Sildenafil differentially affects emotional and socio-sexual behavior in mice","volume":"253","author":"Dadomo","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1464-5491.2007.02338.x","article-title":"Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction","volume":"25","author":"Hatzichristou","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib21","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.2174\/138161209789206980","article-title":"PDE5 inhibitors in non-urological conditions","volume":"15","author":"Vlachopoulos","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.sxmr.2015.12.005_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4111\/kju.2012.53.6.377","article-title":"Chronic low dosing of phosphodiesterase type 5 inhibitor for erectile dysfunction","volume":"53","author":"Sung","year":"2012","journal-title":"Korean J Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1517\/14656566.2012.693162","article-title":"Chronic PDE-5 inhibition in patients with erectile dysfunction: A treatment approach using tadalafil once-daily","volume":"13","author":"Porst","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.sxmr.2015.12.005_bib24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/14656566.2013.799665","article-title":"An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors","volume":"14","author":"Bruzziches","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.sxmr.2015.12.005_bib25","first-page":"2039","article-title":"Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil","volume":"6","author":"Wrishko","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib26","first-page":"292","article-title":"Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil","volume":"1","author":"McMahon","year":"2004","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib27","first-page":"415","article-title":"Comparison of efficacy, safety, and tolerability of\u00a0on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction","volume":"2","author":"McMahon","year":"2005","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.eururo.2006.02.052","article-title":"Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"50","author":"Porst","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib29","first-page":"2160","article-title":"Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction","volume":"5","author":"Porst","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.ijir.3901496","article-title":"Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US","volume":"19","author":"Rajfer","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijir.2009.29","article-title":"Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success","volume":"22","author":"Shabsigh","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4111\/kju.2010.51.9.647","article-title":"Efficacy and safety of tadalafil 5 mg administered once daily in Korean men with erectile dysfunction: a prospective, multicenter study","volume":"51","author":"Kang","year":"2010","journal-title":"Korean J Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.eururo.2011.03.025","article-title":"Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"60","author":"Zhao","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib34","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00120-009-2089-y","article-title":"Chronic PDE-5 inhibition in patients with erectile dysfunction: new treatment approach using once daily tadalafil","volume":"48","author":"Porst","year":"2009","journal-title":"Urologe A"},{"key":"10.1016\/j.sxmr.2015.12.005_bib35","first-page":"1052","article-title":"Daily medication of low-dose tadalafil improves endothelial function and erectile hardness of ED patients","volume":"16","author":"Huang","year":"2010","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib36","first-page":"1014","article-title":"Low-dose tadalafil improves arterial erectile dysfunction","volume":"15","author":"Xu","year":"2009","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib37","first-page":"1147","article-title":"Efficacy of low-dose tadalafil on ED assessed by Self-Esteem and Relationship Questionnaire","volume":"16","author":"Li","year":"2010","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib38","first-page":"860","article-title":"Standard doses of tadalafil for different ED patients","volume":"16","author":"Chen","year":"2010","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib39","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.urology.2014.02.019","article-title":"Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction","volume":"83","author":"Goldfischer","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2015.12.005_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1185\/03007995.2014.989317","article-title":"Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil","volume":"31","author":"Kim","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.sxmr.2015.12.005_bib41","first-page":"1314","article-title":"Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily","volume":"6","author":"Rubio-Aurioles","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib42","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.urology.2009.11.066","article-title":"Impact of tadalafil once daily in men with erectile dysfunction \u2013 including a report of the partners' evaluation","volume":"75","author":"Althof","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2015.12.005_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ijir.2009.22","article-title":"Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily","volume":"21","author":"Seftel","year":"2009","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/and.12216","article-title":"Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction","volume":"47","author":"Cui","year":"2015","journal-title":"Andrologia"},{"key":"10.1016\/j.sxmr.2015.12.005_bib45","first-page":"542","article-title":"Clinical efficacy of daily low-dose tadalafil on erectile dysfunction-no sexual life","volume":"19","author":"Zhang","year":"2013","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib46","first-page":"241","article-title":"Low-dose daily de-escalatory administration of tadalafil for psychological erectile dysfunction","volume":"19","author":"Huang","year":"2013","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib47","doi-asserted-by":"crossref","first-page":"E378","DOI":"10.5489\/cuaj.1736","article-title":"Sildenafil can induce the onset of a cluster headache bout","volume":"8","author":"Lin","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.sxmr.2015.12.005_bib48","first-page":"3","article-title":"Viagra: new warning with protease inhibitors","volume":"318","author":"James","year":"1999","journal-title":"AIDS Treat News"},{"key":"10.1016\/j.sxmr.2015.12.005_bib49","first-page":"1140","article-title":"Yangjing capsule plus low-dose tadalafil for functional anejaculation","volume":"18","author":"Jin","year":"2012","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bmt.1703421","article-title":"Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies","volume":"29","author":"Chatterjee","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.sxmr.2015.12.005_bib51","first-page":"988","article-title":"Antidepressant-induced inhibition of genital vascular responses is reversed by vardenafil in female rabbits","volume":"3","author":"Angulo","year":"2006","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib52","first-page":"429","article-title":"Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study","volume":"6","author":"van der Made","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib53","first-page":"777","article-title":"The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction","volume":"6","author":"van der Made","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib54","first-page":"1077","article-title":"Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism","volume":"3","author":"Burnett","year":"2006","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib55","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.urology.2005.11.045","article-title":"Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism","volume":"67","author":"Burnett","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2015.12.005_bib56","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"127","author":"Burnett","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib57","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.ijir.3901513","article-title":"Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: A pilot study","volume":"19","author":"Aversa","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ijir.2010.12","article-title":"Testosterone and chronic sildenafil\/tadalafil anti-apoptotic role in aged diabetic rats","volume":"22","author":"Mostafa","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib59","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1439-0272.2012.01294.x","article-title":"Effect of testosterone and frequent low-dose sildenafil\/tadalafil on cavernous tissue oxidative stress of aged diabetic rats","volume":"44","author":"Mostafa","year":"2012","journal-title":"Andrologia"},{"key":"10.1016\/j.sxmr.2015.12.005_bib60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.lfs.2011.12.019","article-title":"Evaluation of vitamin E in the treatment of erectile dysfunction in aged rats","volume":"90","author":"Helmy","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.sxmr.2015.12.005_bib61","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.urology.2012.12.068","article-title":"Effect of chronic low-dose tadalafil on penile cavernous tissues in diabetic rats","volume":"81","author":"Mostafa","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2015.12.005_bib62","first-page":"1717","article-title":"Effect of tadalafil therapy upon penile cavernous tissues in spontaneously hypertensive rats","volume":"89","author":"Wu","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.sxmr.2015.12.005_bib63","first-page":"705","article-title":"Chronic vardenafil treatment improves erectile function via structural maintenance of penile corpora cavernosa in rats with acute arteriogenic erectile dysfunction","volume":"8","author":"Hotta","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib64","first-page":"1228","article-title":"Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study","volume":"180","author":"Roehrborn","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib65","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.eururo.2008.01.075","article-title":"A\u00a0randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"53","author":"Stief","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib66","first-page":"1071","article-title":"Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial","volume":"177","author":"McVary","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib67","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.eururo.2012.02.033","article-title":"A\u00a0systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with \u03b1-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"61","author":"Gacci","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib68","first-page":"681","article-title":"The positive effect of sildenafil on LUTS from BPH while treating ED","volume":"10","author":"Ying","year":"2004","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib69","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5527\/wjn.v4.i1.138","article-title":"Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia?","volume":"4","author":"Zhang","year":"2015","journal-title":"World J Nephrol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib70","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.eururo.2011.08.005","article-title":"Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial","volume":"60","author":"Porst","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib71","first-page":"271","article-title":"Tadalafil 2.5 or 5\u00a0mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study","volume":"9","author":"Egerdie","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib72","first-page":"1935","article-title":"Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men","volume":"172","author":"Kloner","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib73","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.eururo.2007.01.033","article-title":"Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction","volume":"51","author":"Kaplan","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib74","first-page":"2170","article-title":"Comparative efficacy assessment of tamsulosin vs tamsulosin plus tadalafil in the treatment of LUTS\/BPH. Pilot study","volume":"5","author":"Bechara","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib75","first-page":"544","article-title":"Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction: Preliminary report","volume":"6","author":"Liguori","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib76","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/aja.2010.177","article-title":"An open, comparative, multicentre clinical study of combined oral therapy with sildenafil and doxazosin GITS for treating Chinese patients with erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"13","author":"Jin","year":"2011","journal-title":"Asian J Androl"},{"key":"10.1016\/j.sxmr.2015.12.005_bib77","first-page":"1624","article-title":"A\u00a0randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"9","author":"Gacci","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib78","first-page":"397","article-title":"Combined tadalafil and \u03b1-blocker therapy for benign prostatic hyperplasia in patients with erectile dysfunction: a multicenter, prospective study","volume":"33","author":"Lee","year":"2012","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.sxmr.2015.12.005_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00345-009-0484-z","article-title":"Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction","volume":"28","author":"Tuncel","year":"2010","journal-title":"World J Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib80","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.urology.2011.11.040","article-title":"Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant \u03b11-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial","volume":"79","author":"Goldfischer","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2015.12.005_bib81","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1464-410X.2008.07515.x","article-title":"Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil","volume":"101","author":"Bannowsky","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2015.12.005_bib82","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1007\/s00120-010-2453-y","article-title":"Nerve-sparing radical prostatectomy with nightly low-dose sildenafil: rehabilitation of erectile function","volume":"49","author":"Bannowsky","year":"2010","journal-title":"Urologe A"},{"key":"10.1016\/j.sxmr.2015.12.005_bib83","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1464-410X.2009.08601_1.x","article-title":"Recovery of erectile function after nerve-sparing radical prostatectomy:improvement with nightly low-dose sildenafil","volume":"103","author":"Mevcha","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2015.12.005_bib84","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4103\/1008-682X.126377","article-title":"Impact of penile rehabilitation with low-dose vardenafil on recovery of erectile function in Japanese men following nerve-sparing radical prostatectomy","volume":"16","author":"Nakano","year":"2014","journal-title":"Asian J Androl"},{"key":"10.1016\/j.sxmr.2015.12.005_bib85","first-page":"1448","article-title":"Increasing the dose of vardenafil on a daily basis does not improve erectile function after unilateral nerve-sparing radical prostatectomy","volume":"9","author":"Bannowsky","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib86","first-page":"539","article-title":"Low-dose tadalafil for erectile dysfunction following pelvic fracture-induced urethral injury: clinical observation of 42 cases","volume":"19","author":"Tang","year":"2013","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib87","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.eururo.2013.09.051","article-title":"Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT)","volume":"65","author":"Montorsi","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib88","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bju.12253","article-title":"Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo","volume":"112","author":"Pavlovich","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2015.12.005_bib89","first-page":"2814","article-title":"Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage","volume":"9","author":"Kovanecz","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1464-410X.2007.07223.x","article-title":"Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection","volume":"101","author":"Kovanecz","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2015.12.005_bib91","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1464-410X.2010.09343.x","article-title":"Early intervention with phosphodiesterase-5 inhibitors after prostate brachytherapy improves subsequent erectile function","volume":"106","author":"Pahlajani","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2015.12.005_bib92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.brachy.2014.08.045","article-title":"Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil","volume":"14","author":"Pugh","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.sxmr.2015.12.005_bib93","first-page":"137","article-title":"Protective effect of sildenafil citrate on contralateral testis injury after unilateral testicular torsion\/detorsion","volume":"66","author":"Y\u00edld\u00edz","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.sxmr.2015.12.005_bib94","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejogrb.2011.07.023","article-title":"Effects of sildenafil citrate on torsion\/detorsion-induced changes in red blood cell and plasma lipid peroxidation, antioxidants, and blood hematology of male rats. 40","volume":"159","author":"Yildiz","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib95","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1439-0272.2011.01181.x","article-title":"Dose-dependent protective effect of sildenafil citrate on testicular injury after torsion\/detorsion in rats","volume":"44","author":"Y\u0131ld\u0131z","year":"2012","journal-title":"Andrologia"},{"key":"10.1016\/j.sxmr.2015.12.005_bib96","first-page":"214","article-title":"Protective effect of tadalafil against ischemia-reperfusion injury in rats","volume":"21","author":"Wu","year":"2015","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.sxmr.2015.12.005_bib97","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/j.1523-1755.2005.00669.x","article-title":"Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage","volume":"68","author":"Rodr\u00edguez-Iturbe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.sxmr.2015.12.005_bib98","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jpedsurg.2014.12.013","article-title":"Dose dependent protective effects of vardenafil on ischemia-reperfusion injury with biochemical and histopathologic evaluation in rat ovary","volume":"50","author":"Yurtcu","year":"2015","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.sxmr.2015.12.005_bib99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.urology.2014.02.050","article-title":"Efficacy of daily low-dose sildenafil for treating interstitial cystitis: results of a randomized, double-blind, placebo-controlled trial \u2013 treatment of interstitial cystitis\/painful bladder syndrome with low-dose sildenafil","volume":"84","author":"Chen","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2015.12.005_bib100","first-page":"1472","article-title":"The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes","volume":"8","author":"Chung","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib101","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.healun.2009.04.013","article-title":"Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition","volume":"28","author":"Botha","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.sxmr.2015.12.005_bib102","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2007.03.118","article-title":"Sildenafil improves the alveolar-capillary function in heart failure patients","volume":"126","author":"Bussotti","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib103","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/clc.20917","article-title":"The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease","volume":"34","author":"Zeng","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib104","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-010-2065-4","article-title":"Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease","volume":"37","author":"Fraisse","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib105","first-page":"474","article-title":"Effects of iloprost combined with low dose tadalafil in adult congenital heart disease patients with severe pulmonary arterial hypertension: a single-center, open-label controlled study","volume":"42","author":"Zhang","year":"2014","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.sxmr.2015.12.005_bib106","first-page":"213","article-title":"Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5","volume":"28","author":"Das","year":"2002","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib107","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10557-005-6894-2","article-title":"Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model","volume":"19","author":"du Toit","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.sxmr.2015.12.005_bib108","doi-asserted-by":"crossref","first-page":"H342","DOI":"10.1152\/ajpheart.00306.2006","article-title":"Sildenafil-mediated acute cardioprotection is independent of the NO\/cGMP pathway","volume":"292","author":"Elrod","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib109","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1211\/jpp.62.03.0009","article-title":"Dose-dependent effects of sildenafil on post-ischaemic left ventricular function in the rat isolated heart","volume":"62","author":"Kolettis","year":"2010","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jns.2015.10.041","article-title":"Impaired vascular endothelial function in patients with restless legs syndrome: a new aspect of the vascular pathophysiology","volume":"359","author":"Koh","year":"2015","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.sxmr.2015.12.005_bib111","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0735-1097(00)00790-7","article-title":"Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure","volume":"36","author":"Katz","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib112","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/diacare.25.8.1336","article-title":"Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes","volume":"25","author":"Desouza","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.sxmr.2015.12.005_bib113","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.transproceed.2007.08.077","article-title":"Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure","volume":"39","author":"Maruszewski","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.sxmr.2015.12.005_bib114","first-page":"927","article-title":"Tadalafil attenuates graft arteriosclerosis of aortic transplant in a rat model","volume":"18","author":"Ziqiang","year":"2015","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.sxmr.2015.12.005_bib115","first-page":"99","article-title":"Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review","volume":"10","author":"Henrie","year":"2015","journal-title":"Core Evid"},{"key":"10.1016\/j.sxmr.2015.12.005_bib116","first-page":"404","article-title":"Chronic oral sildenafil therapy in severe pulmonary artery hypertension","volume":"54","author":"Kothari","year":"2002","journal-title":"Indian Heart J"},{"key":"10.1016\/j.sxmr.2015.12.005_bib117","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1017\/S1047951106001193","article-title":"Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources","volume":"17","author":"Vida","year":"2007","journal-title":"Cardiol Young"},{"key":"10.1016\/j.sxmr.2015.12.005_bib118","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1164\/rccm.200907-0988OC","article-title":"Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension","volume":"181","author":"Blanco","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib119","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A\u00a0randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.sxmr.2015.12.005_bib120","first-page":"CD005494","article-title":"Sildenafil for pulmonary hypertension in neonates","volume":"8","author":"Shah","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sxmr.2015.12.005_bib121","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.105.603001","article-title":"Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: A preliminary observational study","volume":"114","author":"Mukhopadhyay","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.sxmr.2015.12.005_bib122","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.sxmr.2015.12.005_bib123","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.mvr.2005.03.001","article-title":"Use of tadalafil in a patient with a secondary Raynaud's phenomenon not responding to sildenafil","volume":"69","author":"Baumhaekel","year":"2005","journal-title":"Microvasc Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib124","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archinte.166.2.231","article-title":"Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease","volume":"166","author":"Caglayan","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib125","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00296-014-3025-z","article-title":"Effects of phosphodiesterase type 5 inhibitors on Raynaud's phenomenon","volume":"34","author":"Kamata","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.sxmr.2015.12.005_bib126","first-page":"888","article-title":"Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil","volume":"7","author":"Ambach","year":"2009","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.sxmr.2015.12.005_bib127","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1534734607308731","article-title":"Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma","volume":"6","author":"Wollina","year":"2007","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.sxmr.2015.12.005_bib128","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00520-014-2465-z","article-title":"Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study","volume":"23","author":"Meadows","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.sxmr.2015.12.005_bib129","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/2193-1801-3-559","article-title":"Potential effect of Sildenafil beyond pulmonary hypertension in a patient with diffuse systemic sclerosis and cryoglobulinemic vasculitis","volume":"3","author":"Gheita","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.sxmr.2015.12.005_bib130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.18433\/J3TC7V","article-title":"An old drug for a new application: potential benefits of sildenafil in wound healing","volume":"15","author":"Farsaie","year":"2012","journal-title":"J\u00a0Pharm Pharm Sci"},{"key":"10.1016\/j.sxmr.2015.12.005_bib131","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1517\/17425247.2014.929662","article-title":"Novel microstructured sildenafil dosage forms as wound healing promoters","volume":"11","author":"Samy","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.sxmr.2015.12.005_bib132","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/iwj.12104","article-title":"Sildenafil in the treatment of pressure ulcer: a randomised clinical trial","volume":"12","author":"Farsaei","year":"2015","journal-title":"Int Wound J"},{"key":"10.1016\/j.sxmr.2015.12.005_bib133","first-page":"e45","article-title":"Effects of systemic tadalafil on skin flap survival in rats","volume":"12","author":"Brewer","year":"2012","journal-title":"Eplasty"},{"key":"10.1016\/j.sxmr.2015.12.005_bib134","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2982.2007.00957.x","article-title":"Sildenafil relieves symptoms and normalizes motility in patients with oesophageal spasm: a report of two cases","volume":"19","author":"Fox","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.sxmr.2015.12.005_bib135","first-page":"CD003431","article-title":"Non surgical therapy for anal fissure","volume":"2","author":"Nelson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sxmr.2015.12.005_bib136","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/bjs.5724","article-title":"Relaxation of the isolated human internal anal sphincter by sildenafil","volume":"94","author":"Ballester","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.sxmr.2015.12.005_bib137","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10350-003-0110-x","article-title":"Manometric study of topical sildenafil (Viagra) in patients with chronic anal fissure: sildenafil reduces anal resting tone","volume":"47","author":"Torrabadella","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.sxmr.2015.12.005_bib138","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/codi.12359","article-title":"The daily intake of Tadalafil 5 mg improves the symptoms of chronic anal fissure","volume":"15","author":"Marino","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.sxmr.2015.12.005_bib139","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/01.PCC.0000113266.26638.AD","article-title":"Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia","volume":"5","author":"Keller","year":"2004","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.sxmr.2015.12.005_bib140","first-page":"271","article-title":"Congenital diaphragmatic hernia: experience of 14 years","volume":"65","author":"Rocha","year":"2013","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.sxmr.2015.12.005_bib141","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.transproceed.2012.04.003","article-title":"Sildenafil accelerates liver regeneration after partial hepatectomy in rats","volume":"44","author":"Yardimci","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.sxmr.2015.12.005_bib142","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0015-0282(02)03375-7","article-title":"Effect of vaginal sildenafil on the outcome of in\u00a0vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development","volume":"78","author":"Sher","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.sxmr.2015.12.005_bib143","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1933719109354648","article-title":"Sildenafil increases uterine blood flow in nonpregnant nulliparous women","volume":"17","author":"Hale","year":"2010","journal-title":"Reprod Sci"},{"key":"10.1016\/j.sxmr.2015.12.005_bib144","first-page":"26","article-title":"The effect of vaginal sildenafil citrate on uterine blood flow and endometrium in the infertile women","volume":"52","author":"Malinova","year":"2013","journal-title":"Akush Ginekol (Sofiia)"},{"key":"10.1016\/j.sxmr.2015.12.005_bib145","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.fertnstert.2007.08.043","article-title":"Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriage","volume":"90","author":"Jerzak","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.sxmr.2015.12.005_bib146","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3109\/09513590.2014.900034","article-title":"The contribution of sildenafil (Viagra) to ovarian stimulation with gonadotropins in a woman with poor ovarian response","volume":"30","author":"Trakakis","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib147","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.fertnstert.2006.11.182","article-title":"In\u00a0vitro sildenafil citrate use as a sperm motility stimulant","volume":"88","author":"Mostafa","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.sxmr.2015.12.005_bib148","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1439-0272.2006.00752.x","article-title":"Tadalafil as an in\u00a0vitro sperm motility stimulant","volume":"39","author":"Mostafa","year":"2007","journal-title":"Andrologia"},{"key":"10.1016\/j.sxmr.2015.12.005_bib149","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ijir.2008.29","article-title":"Oral phosphodiesterase-5 inhibitors and sperm functions","volume":"20","author":"Mostafa","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib150","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1742-1241.2006.01087.x","article-title":"PDE5 inhibitors in diabetic peripheral neuropathy","volume":"60","author":"Hackett","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.sxmr.2015.12.005_bib151","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.physbeh.2015.07.030","article-title":"Protective effect of exercise and sildenafil on acute stress and cognitive function","volume":"151","author":"Ozbeyli","year":"2015","journal-title":"Physiol Behav"},{"key":"10.1016\/j.sxmr.2015.12.005_bib152","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1523\/JNEUROSCI.0864-09.2009","article-title":"Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model","volume":"29","author":"Puzzo","year":"2009","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.sxmr.2015.12.005_bib153","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2012.06.052","article-title":"Tadalafil crosses the blood-brain barrier and reverses cognitive\u00a0dysfunction in a mouse model of AD","volume":"64","author":"Garc\u00eda-Barroso","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.sxmr.2015.12.005_bib154","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/15376516.2013.770109","article-title":"Sildenafil citrate attenuates the deleterious effects of elevated ammonia","volume":"23","author":"Arafa","year":"2013","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.sxmr.2015.12.005_bib155","first-page":"1137","article-title":"Antinociceptive effect of vardenafil on carrageenan-induced hyperalgesia in rat: involvement of nitric oxide\/cyclic guanosine monophosphate\/calcium channels pathway","volume":"14","author":"Gediz","year":"2015","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.sxmr.2015.12.005_bib156","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WNF.0b013e31815cd94c","article-title":"Role of sildenafil in neurological disorders","volume":"31","author":"Farooq","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.sxmr.2015.12.005_bib157","first-page":"139","article-title":"Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors","volume":"12","author":"Campbell","year":"2015","journal-title":"J\u00a0Sex Med"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052115000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T04:16:12Z","timestamp":1718424972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052115000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":157,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2050052115000554"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2015.12.005","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Useful Implications of Low-dose Long-term Use of PDE-5 Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}